Skip to main content
. 2021 Jun 26;59:94–101. doi: 10.1016/j.breast.2021.06.011

Table 1.

Distribution of patient baseline characteristics.

Variable Level EIO (N = 44) JBI (N = 30) P-value Overall (N = 74)
Year of surgery, N (%) Before 2003 15 (34) 9 (30) 0.49 24 (32)
2003–2006 12 (27) 8 (27) 20 (27)
2007–2010 10 (23) 4 (13) 14 (19)
After 2010 7 (16) 9 (30) 16 (22)
Age (years), N (%) <40 2 (5) 1 (3) 0.97 3 (4)
40–49 6 (14) 4 (13) 10 (14)
50–59 8 (18) 7 (23) 15 (20)
60+ 28 (64) 18 (60) 46 (62)
Median (IQR) 66 (53–71) 64 (53–71) 65 (53–71)
Menopausal status, N (%) Premenopausal 7 (16) 7 (23) 0.55 14 (19)
Postmenopausal 37 (84) 23 (77) 60 (81)
pN, N (%) pN0 16 (36) 20 (67) 0.09 36 (49)
pN1 9 (20) 5 (17) 14 (19)
pN2 5 (11) 1 (3) 6 (8)
pN3 10 (23) 4 (13) 14 (19)
pNX 4 (9) 0 4 (5)
pT, N (%) pT0 0 3 (10) 0.14 3 (4)
pT1 21 (48) 11 (37) 32 (43)
pT2 15 (34) 8 (27) 23 (31)
pT3/4 8 (18) 8 (27) 16 (22)
Tumor grade, N (%) G1 1 (2) 1 (3) <0.001 2 (3)
G2 13 (30) 25 (83) 38 (51)
G3 22 (50) 4 (13) 26 (35)
Unknown 8 (18) 0 8 (11)
Peritumoral vascular invasion, N (%) No 32 (73) 26 (87) 0.25 58 (78)
Yes 12 (27) 4 (13) 16 (22)
Neo-adjuvant treatment, N (%) No therapy 38 (86) 23 (77) 0.01 61 (82)
ET 0 1 (3) 1 (1)
CT 1 (2) 6 (20) 7 (9)
CT + ET 1 (2) 0 1 (1)
Unknown 4 (9) 0 4 (5)
Local treatment, N (%) Mastectomy w/o RT 14 (32) 9 (30) 0.16 23 (31)
Mastectomy w RT 7 (16) 11 (37) 18 (24)
Quadrantectomy w/o RT 4 (9) 3 (10) 7 (9)
Quadrantectomy w RT 19 (43) 7 (23) 26 (35)
Adjuvant treatment, N (%) No therapy 5 (11) 10 (33) 0.007 15 (20)
ET 2 (5) 3 (10) 5 (7)
CT 34 (77) 12 (40) 46 (62)
CT + ET 2 (5) 5 (17) 7 (9)
Unknown 1 (2) 0 1 (1)
Ki67 (%) Median (IQR) 22 (13–34) 10 (10–15) 0.001 15 (10–30)